Plasma Globotriaosylsphingosine Level as a Primary Screening Target for Fabry Disease in Patients With Left Ventricular Hypertrophy.
Yamashita S, Saotome M, Satoh H, Kajihara J, Mochizuki Y, Mizuno K, Nobuhara M, Miyajima K, Kumazawa A, Tominaga H, Takase H, Tawarahara K, Wakahara N, Matsunaga M, Wakabayashi Y, Matsumoto Y, Terada H, Sano M, Ohtani H, Urushida T, Hayashi H, Ishii S, Maruyama H, Maekawa Y.
Yamashita S, et al. Among authors: kumazawa a.
Circ J. 2019 Aug 23;83(9):1901-1907. doi: 10.1253/circj.CJ-19-0110. Epub 2019 Jul 12.
Circ J. 2019.
PMID: 31308318
Free article.